Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Cited In for PubMed (Select 18990233)

1.

Combination of cyclopamine and tamoxifen promotes survival and migration of mcf-7 breast cancer cells--interaction of Hedgehog-Gli and estrogen receptor signaling pathways.

Sabol M, Trnski D, Uzarevic Z, Ozretic P, Musani V, Rafaj M, Cindric M, Levanat S.

PLoS One. 2014 Dec 12;9(12):e114510. doi: 10.1371/journal.pone.0114510. eCollection 2014.

2.

Genetic variants in fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival.

Yin J, Liu H, Liu Z, Wang LE, Chen WV, Zhu D, Amos CI, Fang S, Lee JE, Wei Q.

J Invest Dermatol. 2015 Feb;135(2):542-50. doi: 10.1038/jid.2014.416. Epub 2014 Sep 22.

PMID:
25243787
3.

The roles of Jumonji-type oxygenases in human disease.

Johansson C, Tumber A, Che K, Cain P, Nowak R, Gileadi C, Oppermann U.

Epigenomics. 2014 Feb;6(1):89-120. doi: 10.2217/epi.13.79. Review.

4.

Single nucleotide polymorphism array profiling of adrenocortical tumors--evidence for an adenoma carcinoma sequence?

Ronchi CL, Sbiera S, Leich E, Henzel K, Rosenwald A, Allolio B, Fassnacht M.

PLoS One. 2013 Sep 16;8(9):e73959. doi: 10.1371/journal.pone.0073959. eCollection 2013.

5.

Multiple self-healing squamous epithelioma (MSSE): rare variants in an adjacent region of chromosome 9q22.3 to known TGFBR1 mutations suggest a digenic or multilocus etiology.

Kang HC, Quigley DA, Kim IJ, Wakabayashi Y, Ferguson-Smith MA, D'Alessandro M, Birgitte Lane E, Akhurst RJ, Goudie DR, Balmain A.

J Invest Dermatol. 2013 Jul;133(7):1907-10. doi: 10.1038/jid.2013.45. Epub 2013 Jan 28. No abstract available.

6.

Molecular pathways: targeting PARP in cancer treatment.

Do K, Chen AP.

Clin Cancer Res. 2013 Mar 1;19(5):977-84. doi: 10.1158/1078-0432.CCR-12-0163. Epub 2012 Dec 26.

7.

The association of DNA Repair with breast cancer risk in women. A comparative observational study.

Matta J, Echenique M, Negron E, Morales L, Vargas W, Gaetan FS, Lizardi ER, Torres A, Rosado JO, Bolaños G, Cruz JG, Laboy J, Barnes R, Medina SS, Romero A, Martinez R, Dutil J, Suarez E, Alvarez-Garriga C, Bayona M.

BMC Cancer. 2012 Oct 22;12:490. doi: 10.1186/1471-2407-12-490.

8.

An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells.

Yamamoto Y, Yoshioka Y, Minoura K, Takahashi RU, Takeshita F, Taya T, Horii R, Fukuoka Y, Kato T, Kosaka N, Ochiya T.

Mol Cancer. 2011 Nov 3;10:135. doi: 10.1186/1476-4598-10-135.

9.

Structural basis for human PHF2 Jumonji domain interaction with metal ions.

Horton JR, Upadhyay AK, Hashimoto H, Zhang X, Cheng X.

J Mol Biol. 2011 Feb 11;406(1):1-8. doi: 10.1016/j.jmb.2010.12.013. Epub 2010 Dec 15.

10.

Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents.

Palagyi A, Neveling K, Plinninger U, Ziesch A, Targosz BS, Denk GU, Ochs S, Rizzani A, Meier D, Thasler WE, Hanenberg H, De Toni EN, Bassermann F, Schäfer C, Göke B, Schindler D, Gallmeier E.

Mol Cancer. 2010 May 28;9:127. doi: 10.1186/1476-4598-9-127.

11.

Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations.

Carter H, Chen S, Isik L, Tyekucheva S, Velculescu VE, Kinzler KW, Vogelstein B, Karchin R.

Cancer Res. 2009 Aug 15;69(16):6660-7. doi: 10.1158/0008-5472.CAN-09-1133. Epub 2009 Aug 4.

12.

Histone demethylases and cancer.

Kampranis SC, Tsichlis PN.

Adv Cancer Res. 2009;102:103-69. doi: 10.1016/S0065-230X(09)02004-1. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk